Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2025-12-25 @ 12:13 PM
NCT ID:
NCT03824561
Pre Assignment Details:
Participants with ulcerative colitis who received Vedolizumab IV infusion 300 mg were enrolled. Participants received Vedolizumab IV infusion 300 mg as part of a routine normal practice.
Recruitment Details:
Participants took part in the study at 197 investigative sites in Japan, from 1 February 2019 to 12 February 2025.
Study:
NCT03824561
Study Brief:
Results Section:
NCT03824561